Bupropion and Weight Loss
Links shared publicly online about this topic
Effect of naltrexone plus bupropion on weight loss... [Lancet. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on August 30, 2010 at 2:18 pm By:
Moderately effective medical therapy for #obesity in good-quality trial: bupropion + naltrexone. http://bit.ly/9wSqCT
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial : The Lancet
thelancet.com — “Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. By - Prof Frank L Greenway MD,...” View full resource at thelancet.com
Most Recently Shared on August 22, 2010 at 1:41 am By:
Combination Weight Loss Drugs Appear Effective for Obesity. http://bit.ly/cjn0cN
Former GSK Lawyer Charged in Bupropion Coverup - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The U.S. Department of Justice has charged a former vice president and lawyer at GlaxoSmithKline with trying to cover up evidence that the company was illegally marketing the depression drug bupropion (Wellbutrin) as a weight-loss aid.” View full resource at qualitypointtech.net
Most Recently Shared on November 10, 2010 at 11:50 pm By:
Former GSK Lawyer Charged in Bupropion Coverup: (MedPage Today) -- The U.S. Department of Justice has charged a fo... http://bit.ly/c0qQ32
Comparison of combined bupropion and naltrexone th... [J Clin Endocrinol Metab. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on January 8, 2010 at 3:48 pm By:
Naltrexone/bupropion combo therapy effective for weight loss in randomized clinical trial. http://ow.ly/UeQY
FDA Panel Endorses Contrave Weight-Loss Drug - ABC News
abcnews.go.com — “An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood pressure risk.” View full resource at abcnews.go.com
Most Recently Shared on December 8, 2010 at 1:23 pm By:
FDA panel recommends diet pill despite little benefit compared to placebo and real heart risks. Thumbs down! http://ow.ly/3lTsY
Combination Naltrexone And Bupropion For Obesity Leads To Substantial Reductions In Bodyweight
medicalnewstoday.com — “Combination treatment for obesity using the drugs naltrexone and bupropion, plus diet and exercise, helps reduce bodyweight by a mean of 5% or more over a year, depending on the dosage used. The f” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 11:43 am By:
#obesity - Good study on naltrexone & bupropion (with diet & exercise) for weight reduction - a good combination;... http://fb.me/t9suo6ZR
FDA denies approval of weight-loss drug
endocrinetoday.com — “The FDA has issued a complete response letter regarding the new drug application for combination naltrexone plus bupropion extended-release tabl” View full resource at endocrinetoday.com
Most Recently Shared on February 1, 2011 at 2:07 pm By:
FDA Says No to Weight-Loss Combo Drug Contrave - ABC News
abcnews.go.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at abcnews.go.com
Most Recently Shared on February 5, 2011 at 1:27 pm By:
Medical News: Panel Endorses Weight-Loss Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood p” View full resource at medpagetoday.com
Most Recently Shared on December 7, 2010 at 11:46 pm By:
Medical News: Weight Counseling, Bupropion Help Smokers Quit - in Primary Care, Smoking & Tobacco from MedPage Today
medpagetoday.com — “Adding bupropion (Wellbutrin, Zyban) to cognitive behavioral therapy intervention that focuses on weight-gain concerns increased smoking cessation rates, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on March 23, 2010 at 2:07 pm By:
Weight Counseling, Bupropion Help Smokers Quit (CME/CE) Adding bupropion (Wellbutrin, Zyban) to cognitive behavioral .. http://bit.ly/b9YczG
Medical News: Weight-Loss Combo Appears Effective - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A sustained-release formulation combining bupropion and naltrexone (Contrave) appears to be an effective treatment for weight loss in obese patients, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on July 30, 2010 at 4:37 pm By:
Weight-Loss Combo Appears Effective (CME/CE) (MedPage Today) -- A sustained-release formulation combining bupropion and.. http://dld.bz/pzez
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:39 pm By:
FDA Says No to Weight-Loss Combo Drug, Contrave, which consists of bupropion and naltrexone. http://bit.ly/g6SOkp
FDA advisory panel approves combination weight-loss drug
endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 13-7 for approval of combination bupropion plus naltrexone for treatment of obe” View full resource at endocrinetoday.com
Most Recently Shared on December 7, 2010 at 2:48 pm By:
#FDA advisory panel will weigh in on proposed weight-loss drug http://ow.ly/3leCm
Phase 2b study of Empatic for weight loss - MPR
empr.com — “Orexigen Therapeutics announced positive results from its Phase 2b trial for Empatic (bupropion SR/zonisamide SR), its investigational combination drug for the treatment of obesity.” View full resource at empr.com
Most Recently Shared on September 30, 2009 at 4:42 pm By:
MPR News: Phase 2b study of Empatic for weight loss: Orexigen Therapeutics announced positive results .. http://tinyurl.com/ydbvnju
An Effective Regimen for Weight Loss? - QualityPoint Technologies
qualitypointtech.net — “Dr. Leslie Citrome reviews a new study in The Lancet suggesting that combination treatment with naltrexone and bupropion is a viable intervention for obesity. Medscape Psychiatry & Mental Health” View full resource at qualitypointtech.net
Most Recently Shared on August 9, 2010 at 4:42 pm By:
An Effective Regimen for Weight Loss?: Dr. Leslie Citrome reviews a new study in The Lancet suggesting that combin... http://bit.ly/bdxLwX
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Zack (Sholem) Berger
Doctor, writer, observant Jew, Yiddish poet/ideologue.
-
Symposier Endocrino
Symposier integrates and categorize medical information from around the world.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement

